Skip to main content

Table 2 Univariate and multivariate analyses of factors predicting HR-HPV clearance

From: The influence of probiotics on genital high-risk human papilloma virus clearance and quality of cervical smear: a randomized placebo-controlled trial

  HR-HPV clearance   Multivariate analysis
Yes (n = 68) No (n = 53) p-value HR (95% CI) p-value
Age, years (mean ± SD) 44.72 ± 10.50 45.00 ± 11.58 0.890 0.494 (0.092, 2.654) 0.623
Post-menopause 21 (30.9%) 16 (30.2%) 0.986 1.007 (0.451, 2.251) 0.848
Parity 1.81 ± 1.01 2.28 ± 1.25 0.030 2.100 (0.949, 4.648) 0.105
IUD 8 (11.8%) 4 (7.6%) 0.752 1.469 (0.405, 5.326) 0.734
Educational level (College or above) 25 (36.7%) 14 (26.4%) 0.310 1.637 (0.725, 3.693) 0.440
Employed 44 (64.7%) 34 (64.1%) 0.846 1.107 (0.513, 2.386) 0.449
History of TH 4 (5.9%) 7 (13.2%) 0.104 0.260 (0.065, 1.032) 0.147
Probiotics used 36 (52.9%) 26 (49.1%) 0.716 1.168 (0.569, 397) 0.672
Viral load (RLU/PC) (mean ± SD) 313.82 ± 616.28 561.88 ± 868.58 0.019 3.214 (1.398, 7.392) 0.006
  1. CI confidence interval, HR hazard ratio, HR-HPV high-risk human papillomavirus, IUD intra-uterine device, RLU/PC relative light unit/positive control, SD standard deviation, TH total hysterectomy